FDA clears Aerocrine asthma device

03/4/2008 | NJBIZ (New Jersey)

Aerocrine has received FDA approval for its Niox Mino, a hand-held device designed to spot and monitor airway inflammation in asthma patients. The company is receiving orders from doctors for the device, which will be be on the market in eight to 12 weeks, Aerocrine's senior adviser said.

View Full Article in:

NJBIZ (New Jersey)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager, Business Conduct
Gilead
Foster City, CA
Sr. Compliance Director Ethics and Compliance
Medtronic
Fridley, MN
Product Patent Attorney
Gilead
Foster City, CA
Employment Counsel
Gilead
Foster City, CA
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC